Tapewire

NYSE · USD

MET

METLIFE INC

Export transactions ↓
Tapewire entity
488
SEC CIK
0001099219
Parsed reports
1,091

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 13, 2018 Filed Dec 14, 2018 21:28 UTC GrantCommon Stock 186.0697 $39.52 $7,353.47
Disclosure

SEC source: 0001209191-18-062729 · doc4.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,694.3414

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2018 Filed Dec 14, 2018 21:25 UTC
KANDARIAN STEVEN ADirector · Chairman, President & CEO
GrantCommon Stock 1,734.8923 $39.52 $68,562.94
Disclosure

SEC source: 0001209191-18-062727 · doc4.xml · nonDerivative · entry 1

KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 519,519.0006

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2018 Filed Dec 14, 2018 21:24 UTC GrantCommon Stock Equivalents · Derivative 219.8536 $39.52 $8,688.61
Disclosure

SEC source: 0001209191-18-062726 · doc4.xml · derivative · entry 2

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219.8536

Underlying: Common Stock · 219.8536 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units.

F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
December 13, 2018 Filed Dec 14, 2018 21:24 UTC GrantCommon Stock 466.9744 $39.52 $18,454.83
Disclosure

SEC source: 0001209191-18-062726 · doc4.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,185.0416

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2018 Filed Dec 14, 2018 21:23 UTC GrantCommon Stock 16.9965 $39.52 $671.70
Disclosure

SEC source: 0001209191-18-062723 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,709.2856

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2018 Filed Dec 14, 2018 21:21 UTC GrantCommon Stock 532.0082 $39.52 $21,024.96
Disclosure

SEC source: 0001209191-18-062717 · doc4.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,299.4476

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2018 Filed Dec 14, 2018 21:22 UTC GrantCommon Stock Equivalents Units · Derivative 11.2006 $39.52 $442.65
Disclosure

SEC source: 0001209191-18-062721 · doc4.xml · derivative · entry 3

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11.2006

Underlying: Common Stock · 11.2006 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units.

F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
December 13, 2018 Filed Dec 14, 2018 21:22 UTC GrantCommon Stock 28.0127 $39.52 $1,107.06
Disclosure

SEC source: 0001209191-18-062721 · doc4.xml · nonDerivative · entry 1

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,663.8755

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
November 01, 2018 Filed Nov 2, 2018 20:33 UTC GrantCommon Stock 420 $41.94 $17,614.80
Disclosure

SEC source: 0001209191-18-056938 · doc4.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. This is a pro-rata amount for the period from November 1, 2018 to December 31, 2018.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:33 UTC GrantCommon Stock 802 $46.77 $37,509.54
Disclosure

SEC source: 0001209191-18-054022 · doc4.xml · nonDerivative · entry 1

MORRISON DENISE M · CIK 0001230166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,634

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:32 UTC GrantCommon Stock 802 $46.77 $37,509.54
Disclosure

SEC source: 0001209191-18-054021 · doc4.xml · nonDerivative · entry 1

Kinney Catherine R · CIK 0001205054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,298.6146

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:32 UTC GrantCommon Stock 802 $46.77 $37,509.54
Disclosure

SEC source: 0001209191-18-054018 · doc4.xml · nonDerivative · entry 1

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,127.3389

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:31 UTC GrantCommon Stock 802 $46.77 $37,509.54
Disclosure

SEC source: 0001209191-18-054015 · doc4.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,508.2717

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:30 UTC GrantCommon Stock Equivalents · Derivative 534.5307 $46.77 $25,000.00
Disclosure

SEC source: 0001209191-18-054011 · doc4.xml · derivative · entry 2

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 534.5307

Underlying: Common Stock · 534.5307 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · kind: The Reporting Person acquired these Common Stock Equivalent Units pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock.

F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:30 UTC GrantCommon Stock 802 $46.77 $37,509.54
Disclosure

SEC source: 0001209191-18-054011 · doc4.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,718.0672

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:30 UTC GrantCommon Stock 802 $46.77 $37,509.54
Disclosure

SEC source: 0001209191-18-054013 · doc4.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,802.7978

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:29 UTC GrantCommon Stock 802 $46.77 $37,509.54
Disclosure

SEC source: 0001209191-18-054009 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,692.2891

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:29 UTC GrantCommon Stock Equivalent Units · Derivative 320.7184 $46.77 $15,000.00
Disclosure

SEC source: 0001209191-18-054007 · doc4.xml · derivative · entry 3

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 320.7184

Underlying: Common Stock · 320.7184 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · kind: The Reporting Person acquired these Common Stock Equivalent Units pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock.

F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:29 UTC GrantCommon Stock 802 $46.77 $37,509.54
Disclosure

SEC source: 0001209191-18-054007 · doc4.xml · nonDerivative · entry 1

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,635.8628

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:28 UTC GrantCommon Stock 802 $46.77 $37,509.54
Disclosure

SEC source: 0001209191-18-054001 · doc4.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,767.4394

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 21:28 UTC GrantCommon Stock 802 $46.77 $37,509.54
Disclosure

SEC source: 0001209191-18-054005 · doc4.xml · nonDerivative · entry 1

GUTIERREZ CARLOS M · CIK 0001185943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,075

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 21:06 UTC GrantCommon Stock 252.737 $45.52 $11,504.59
Disclosure

SEC source: 0001209191-18-051253 · doc4.xml · nonDerivative · entry 1

Kinney Catherine R · CIK 0001205054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,496.6146

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 21:02 UTC GrantCommon Stock Equivalent Units · Derivative 103.9783 $45.52 $4,733.09
Disclosure

SEC source: 0001209191-18-051248 · doc4.xml · derivative · entry 3

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103.9783

Underlying: Common Stock · 103.9783 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · timeliness: Represents imputed reinvestment of dividends on Common Stock Equivalent Units.

F3 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 21:02 UTC GrantCommon Stock 454.5337 $45.52 $20,690.37
Disclosure

SEC source: 0001209191-18-051248 · doc4.xml · nonDerivative · entry 1

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,325.3389

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 20:59 UTC GrantCommon Stock 152.7347 $45.52 $6,952.48
Disclosure

SEC source: 0001209191-18-051245 · doc4.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,706.2717

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 20:56 UTC GrantCommon Stock 109.7156 $45.52 $4,994.25
Disclosure

SEC source: 0001209191-18-051242 · doc4.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000.7978

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 20:53 UTC
KANDARIAN STEVEN ADirector · Chairman, President & CEO
GrantCommon Stock 1,492.4454 $45.52 $67,936.11
Disclosure

SEC source: 0001209191-18-051236 · doc4.xml · nonDerivative · entry 1

KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 517,784.1083

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 20:51 UTC GrantCommon Stock Equivalents · Derivative 184.2427 $45.52 $8,386.73
Disclosure

SEC source: 0001209191-18-051231 · doc4.xml · derivative · entry 2

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184.2427

Underlying: Common Stock · 184.2427 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units.

F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 20:51 UTC GrantCommon Stock 394.3837 $45.52 $17,952.35
Disclosure

SEC source: 0001209191-18-051231 · doc4.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,916.0672

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 20:49 UTC GrantCommon Stock 7.2891 $45.52 $331.80
Disclosure

SEC source: 0001209191-18-051226 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,890.2891

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 20:44 UTC GrantCommon Stock Equivalents Units · Derivative 6.7032 $45.52 $305.13
Disclosure

SEC source: 0001209191-18-051219 · doc4.xml · derivative · entry 3

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6.7032

Underlying: Common Stock · 6.7032 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units.

F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 20:44 UTC GrantCommon Stock 16.7658 $45.52 $763.18
Disclosure

SEC source: 0001209191-18-051219 · doc4.xml · nonDerivative · entry 1

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,833.8628

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 20:41 UTC GrantCommon Stock 450.3292 $45.52 $20,498.99
Disclosure

SEC source: 0001209191-18-051213 · doc4.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,965.4394

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
August 27, 2018 Filed Aug 29, 2018 20:34 UTC
KANDARIAN STEVEN ADirector · Chairman, President & CEO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 59,775 $0.00 Strike: $20.82 $0.00
Disclosure

SEC source: 0001209191-18-048809 · doc4.xml · derivative · entry 4

KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 59,775 shares

Expires 2019-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options became exercisable in three installments on February 24, 2010, February 24, 2011 and February 24, 2012.

Read SEC document
August 27, 2018 Filed Aug 29, 2018 20:34 UTC
KANDARIAN STEVEN ADirector · Chairman, President & CEO
SaleCommon Stock 42,805 $47.03 $2,013,119.15
Disclosure

SEC source: 0001209191-18-048809 · doc4.xml · nonDerivative · entry 2

KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 516,291.6629

F1 · price: The price reported is the weighted average price of the aggregate number of shares purchased in multiple open market transactions. The shares were purchased at prices $47.01 to $47.075, inclusive. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
August 27, 2018 Filed Aug 29, 2018 20:34 UTC
KANDARIAN STEVEN ADirector · Chairman, President & CEO
Exercise / conversionCommon Stock 59,775 $20.82 $1,244,515.50
Disclosure

SEC source: 0001209191-18-048809 · doc4.xml · nonDerivative · entry 1

KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 559,096.6629

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 21, 2018 Filed Aug 23, 2018 20:31 UTC
KANDARIAN STEVEN ADirector · Chairman, President & CEO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 119,549 $0.00 Strike: $20.82 $0.00
Disclosure

SEC source: 0001209191-18-048179 · doc4.xml · derivative · entry 4

KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 119,549 shares

Expires 2019-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 21, 2018 Filed Aug 23, 2018 20:31 UTC
KANDARIAN STEVEN ADirector · Chairman, President & CEO
SaleCommon Stock 85,683 $46.93 $4,021,103.19
Disclosure

SEC source: 0001209191-18-048179 · doc4.xml · nonDerivative · entry 2

KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 499,321.6629

F1 · price: The price reported is the weighted average price of the aggregate number of shares purchased in multiple open market transactions. The shares were purchased at prices $46.91 to $46.965, inclusive. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
August 21, 2018 Filed Aug 23, 2018 20:31 UTC
KANDARIAN STEVEN ADirector · Chairman, President & CEO
Exercise / conversionCommon Stock 119,549 $20.82 $2,489,010.18
Disclosure

SEC source: 0001209191-18-048179 · doc4.xml · nonDerivative · entry 1

KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 585,004.6629

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 13, 2018 Filed Jun 14, 2018 20:49 UTC GrantCommon Stock 139.618 $47.00 $6,562.05
Disclosure

SEC source: 0001209191-18-037760 · doc4.xml · nonDerivative · entry 2

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,553.537

F2 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
June 13, 2018 Filed Jun 14, 2018 20:47 UTC GrantCommon Stock 98.3225 $47.00 $4,621.16
Disclosure

SEC source: 0001209191-18-037758 · doc4.xml · nonDerivative · entry 2

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,891.0822

F2 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
June 13, 2018 Filed Jun 14, 2018 20:47 UTC
KANDARIAN STEVEN ADirector · Chairman, President & CEO
GrantCommon Stock 1,432.6469 $47.00 $67,334.40
Disclosure

SEC source: 0001209191-18-037756 · doc4.xml · nonDerivative · entry 1

KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 474,705.6629

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

F2 · balance_after: Includes 69,000 shares previously reported as indirectly beneficially owned through a Grantor Retained Annuity Trust ("GRAT").

Read SEC document
June 13, 2018 Filed Jun 14, 2018 20:46 UTC GrantCommon Stock Equivalents · Derivative 172.198 $47.00 $8,093.31
Disclosure

SEC source: 0001209191-18-037755 · doc4.xml · derivative · entry 4

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172.198

Underlying: Common Stock · 172.198 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F5 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units.

F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
June 13, 2018 Filed Jun 14, 2018 20:46 UTC GrantCommon Stock 371.5847 $47.00 $17,464.48
Disclosure

SEC source: 0001209191-18-037755 · doc4.xml · nonDerivative · entry 2

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,521.6835

F2 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
June 13, 2018 Filed Jun 14, 2018 20:44 UTC GrantCommon Stock Equivalent Units · Derivative 99.8121 $47.00 $4,691.17
Disclosure

SEC source: 0001209191-18-037753 · doc4.xml · derivative · entry 4

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99.8121

Underlying: Common Stock · 99.8121 shares

Expires not disclosed

F4 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F5 · timeliness: Represents imputed reinvestment of dividends on Common Stock Equivalent Units.

F4 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
June 13, 2018 Filed Jun 14, 2018 20:44 UTC GrantCommon Stock 429.3247 $55.22 $23,707.31
Disclosure

SEC source: 0001209191-18-037753 · doc4.xml · nonDerivative · entry 2

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,870.8052

F2 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
June 13, 2018 Filed Jun 14, 2018 20:43 UTC GrantCommon Stock 235.6134 $47.00 $11,073.83
Disclosure

SEC source: 0001209191-18-037751 · doc4.xml · nonDerivative · entry 2

Kinney Catherine R · CIK 0001205054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,243.8776

F2 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
June 13, 2018 Filed Jun 14, 2018 20:39 UTC GrantCommon Stock Equivalents Units · Derivative 3.637 $47.00 $170.94
Disclosure

SEC source: 0001209191-18-037745 · doc4.xml · derivative · entry 5

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3.637

Underlying: Common Stock · 3.637 shares

Expires not disclosed

F4 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F6 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units.

F4 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
June 13, 2018 Filed Jun 14, 2018 20:39 UTC GrantCommon Stock 9.097 $47.00 $427.56
Disclosure

SEC source: 0001209191-18-037745 · doc4.xml · nonDerivative · entry 2

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,817.097

F2 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
June 13, 2018 Filed Jun 14, 2018 20:38 UTC GrantCommon Stock 425.2886 $47.00 $19,988.56
Disclosure

SEC source: 0001209191-18-037742 · doc4.xml · nonDerivative · entry 2

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,515.1102

F2 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.